Wu K et al’s studies demonstrated that DACH1 blocks mammary tumor growth through downregulating Nanog and Sox2, and reduced DACH1 protein levels correlated significantly with poor prognosis of breast cancer [14, 15]. Here, SOX2 is linked to breast cancer.